𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase III Randomized Trial of Induction Chemotherapy in Patients With N2 or N3 Locally Advanced Head and Neck Cancer

✍ Scribed by Cohen, E. E. W.; Karrison, T. G.; Kocherginsky, M.; Mueller, J.; Egan, R.; Huang, C. H.; Brockstein, B. E.; Agulnik, M. B.; Mittal, B. B.; Yunus, F.; Samant, S.; Raez, L. E.; Mehra, R.; Kumar, P.; Ondrey, F.; Marchand, P.; Braegas, B.; Seiwert, T. Y.; Villaflor, V. M.; Haraf, D. J.; Vokes, E. E.

Book ID
126885196
Publisher
American Society of Clinical Oncology
Year
2014
Tongue
English
Weight
272 KB
Volume
32
Category
Article
ISSN
0732-183X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Induction chemotherapy in head and neck
Induction chemotherapy in head and neck cancer: Results of a phase III trial
✍ Dr. Jean-Jacques Mazeron; Michel Martin; Bernard Brun; Laval Grimard; Gilles Lel πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 661 KB

stage 11-Ill-IV squamous cell carcinoma of the oropharynx or oral cavity were randomized to induction chemotherapy, consisting of bleomycin (10 mg/m\*/day in continuous infusion from day 1 to day 5), methotrexate (120 mg/m2 on day 2) followed by folink acid, 5-fluorouracil (5 FU) (600 mg/m2 on day 2

Long-term survival of resectable subset
Long-term survival of resectable subset after induction chemotherapy in patients with locally advanced head and neck cancer
✍ Yo-Han Cho; Se Hoon Lee; Dong-Wan Kim; Hong-Gyun Wu; J. Hun Hah; Chae-Seo Rhee; πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 169 KB πŸ‘ 1 views

## Abstract ## Background. Although meta‐analysis showed that survival improved with concurrent chemoradiation in locally advanced head and neck cancer, neoadjuvant chemotherapy is still unique, because it renders curative surgery feasible for marginally resectable head and neck cancer patients.